Home> News> HARMONY young talent presenting at the IMI 10th Anniversary Scientific Symposium

HARMONY young talent presenting at the IMI 10th Anniversary Scientific Symposium

October 21, 2018 20:49 - x 00, 0 - 00:00

For the last 10 years, over 100 projects of the Innovative Medicines Initiative (IMI) have been carrying out amazing work to speed up the development of innovative medicines and transform medical research. For that reason, IMI is organizing a 10th-anniversary scientific symposium, where young scientists from IMI projects will present their sterling work. The symposium will take place on 22 and 23 October 2018 in Brussels. It will feature more than 80 poster displays, over 25 oral presentations, and several interesting panels on topics ranging from personalised medicine to patient-centric approaches in drug development. With 53 partners, 27 Associated Members and a budget of 40 million euros, HARMONY is IMI's largest big data project, and we are proud to be part of the IMI family.


Meet HARMONY at the IMI Scientific Symposium! Our presenters:


Oral presentation by María Abáigar-Alvarado, IBSAL, HARMONY Partner

(on day 2, 23 October; 09:30 – 11:15 hrs.)

      

Title of the oral presentation: The HARMONY Data Platform: using Big Data to fight blood Cancers.

Click here to open the PPT > Click here to open the abstract >


Poster presentation by Mattia d’Agostino, University of Turin, HARMONY Partner

(on day 1, 22 October; 17:00 - 19:00 hrs. and on day 2, 23 October; 11:15 – 11:45 and 15:30 – 16:00 hrs.). 

      

Title of the poster: Prognostic factors and outcome of multiple myeloma patients enrolled in European clinical trials after a long-term follow-up. A pilot project by the multiple myeloma community within the HARMONY Alliance.

Click here to open the poster > Click here to open the abstract >


Main objectives of the IMI 10th Anniversary Scientific Symposium are:

Check the 22 and 23 October program >


Kicking off the 10th Anniversary Symposium with Pierre Meulien, Executive Director of the Innovative Medicines Initiative.

 

 


Receive the latest news. Click here to subscribe!